Rydex Inverse Russell 2000 Strategy H
9601 Blackwell Road Suite 500 Rockville MD 20850
Phone: 800-820-0888
| Category: |
Bear Market |
| Fund Family: |
Rydex |
| Net Assets: |
38.36M |
| Year-to-Date Return: |
5.10% |
| Yield: |
3.96% |
| Morningstar Rating: |
N/A |
| Fund Inception Date: |
20-Feb-04 |
|
Michael J. Dellapa
Lead Manager since
30-Jun-06 |
|
| Dellapa joined Rydex Investments in 2000 as a Research Analyst and was promoted to portfolio manager in 2003. During his tenure as a portfolio manager, he had direct oversight for the Russell 2000(R) Advantage, Healthcare, Biotechnology, and Consumer Products Funds, which are offered in a separate prospectus. In 2005, Dellapa became director of investment research. Dellapa holds the Charted Financial Analyst designation. |
| Min Initial Investment: |
$2,500 |
| Min Initial Investment, IRA: |
$1,000 |
| Min Initial Investment, AIP: |
$0 |
| Min Subsequent Investment: |
$0 |
| Min Subsequent Investment, IRA: |
$0 |
| Min Subsequent Investment, AIP: |
$0 |
|
|
|
| The investment seeks to provide investment results that will match the inverse of the performance of Russell 2000 index. The fund normally invests at least 80% of assets in financial instruments with economic characteristics that should perform opposite to those of the underlying index. It may hold short-term U.S. Government securities to collateralize its short sales and derivative positions. The fund is nondiversified. |
| Last Dividend
(6-Dec-07):
|
1.41 |
| Last Cap Gain
|
N/A |
| Annual Holdings Turnover
|
N/A |
| Average for Category:
|
344.36% |
|
| Expense |
RYSHX |
Category
Avg |
| Total Expense Ratio: |
1.65%
|
1.98% |
| Max 12b1 Fee: |
0.25%
|
N/A |
| Max Front End Sales Load: |
0.00%
|
4.75% |
| Max Deferred Sales Load: |
0.00%
|
1.23% |
| 3 Yr Expense Projection*: |
$520 |
$789 |
| 5 Yr Expense Projection*: |
$897 |
$1,290 |
| 10 Yr Expense Projection*: |
$1,955 |
$2,630 |
|
|
Help
0.45 (1.43%) 
Profile
